We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOAT icon
351
VanEck Morningstar Wide Moat ETF
MOAT
$12.3B
$2.13M 0.02%
38,956
+28,538
+274% +$1.56M
TNET icon
352
TriNet
TNET
$3.14B
$2.12M 0.02%
35,805
+31,182
+674% +$2M
ILMN icon
353
Illumina
ILMN
$28.4B
$2.12M 0.02%
7,054
+2,565
+57% +$884K
IYT icon
354
iShares US Transportation ETF
IYT
$2.28B
$2.12M 0.02%
42,648
+42,604
+96,827% +$1.99M
LMT icon
355
Lockheed Martin
LMT
$136B
$2.12M 0.02%
5,527
-3,547
-39% -$1.35M
CNNE icon
356
Cannae Holdings
CNNE
$649M
$2.12M 0.02%
56,786
+49,807
+714% +$1.89M
EAT icon
357
Brinker International
EAT
$9.66B
$2.12M 0.02%
49,528
+17,988
+57% +$627K
BIIB icon
358
Biogen
BIIB
$30.7B
$2.12M 0.02%
7,455
+2,831
+61% +$790K
GTLS
359
DELISTED
Chart Industries
GTLS
$2.12M 0.02%
30,096
+24,955
+485% +$1.62M
APD icon
360
Air Products & Chemicals
APD
$67.6B
$2.11M 0.02%
7,096
+1,845
+35% +$531K
INCY icon
361
Incyte
INCY
$24.4B
$2.11M 0.02%
23,561
+14,354
+156% +$1.38M
DOCU
362
DocuSign
DOCU
$11.5B
$2.11M 0.02%
9,797
+7,776
+385% +$1.61M
OMCL icon
363
Omnicell
OMCL
$1.68B
$2.1M 0.02%
28,122
+21,600
+331% +$1.5M
MPWR icon
364
Monolithic Power Systems
MPWR
$68.9B
$2.1M 0.02%
7,495
-200
-3% -$52K
XYZ
365
Block Inc
XYZ
$47.5B
$2.08M 0.02%
12,786
-26,852
-68% -$3.79M
XLG icon
366
Invesco S&P 500 Top 50 ETF
XLG
$11B
$2.08M 0.02%
79,270
+24,050
+44% +$621K
AMN icon
367
AMN Healthcare
AMN
$1.4B
$2.07M 0.02%
35,443
+30,450
+610% +$1.6M
VC icon
368
Visteon
VC
$2.78B
$2.07M 0.02%
29,934
+19,170
+178% +$1.42M
SBIO icon
369
ALPS Medical Breakthroughs ETF
SBIO
$216M
$2.07M 0.02%
50,323
+41,409
+465% +$1.71M
LLY icon
370
Eli Lilly
LLY
$1.06T
$2.06M 0.02%
13,947
+1,262
+10% +$195K
ZTS icon
371
Zoetis
ZTS
$30B
$2.06M 0.02%
12,450
-34,220
-73% -$5.26M
VSLR
372
DELISTED
VIVINT SOLAR, INC.
VSLR
$2.06M 0.02%
48,582
+35,188
+263% +$907K
FLR icon
373
Fluor
FLR
$7.96B
$2.05M 0.02%
233,185
+124,754
+115% +$1.31M
PCAR icon
374
PACCAR
PCAR
$70.1B
$2.05M 0.02%
36,090
+25,887
+254% +$1.45M
PTC icon
375
PTC
PTC
$16B
$2.05M 0.02%
24,741
+3,938
+19% +$335K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.